頁籤選單縮合
題 名 | Burkholderia Cepacia Bacteremia:A Retrospective Analysis of 70 Episodes=Burkholderia Cepacia菌血症--七十個病例的回溯分析 |
---|---|
作 者 | 盧進德; 張上淳; 陳宜君; 陸坤泰; 李慶雲; 謝維銓; | 書刊名 | 臺灣醫學會雜誌 |
卷 期 | 96:12 1997.12[民86.12] |
頁 次 | 頁972-978 |
分類號 | 415.15 |
關鍵詞 | Burkholderia cepacia菌血症; Burkholderia cepacia; Bacteremia; Nosocomial infection; |
語 文 | 英文(English) |
英文摘要 | Burkholderia Cepacia, a widespread gram-negative environmental bacillus associated with nosocomial infections, is considered to be of relatively low virulence and rarely to cause invasive disease. We retrospectively analyzed the risk factors, clinical manifestations, antimicrobial susceptibilities, and prognostic factors of B. cepacia bacteremia cases. From 1982 through 1995, 70 episodes of bacteremia due to B. cepacia occurred in 52 patients at the National Taiwan University Hospital. The overall case fatality rate was 11%. Sixty-four episodes were nosocomia infections. The common predisposing conditions were stay in an intensive care unit (61%) and invasive procedures, including urinary catheter (54%), intravenous catheter (70%), and intubation (57%). Three episodes involved polymicrobial bacteremia. In 41 episodes in which the infectious focus was identified, the respiratory tract was the most common portal of entry (17/41) followed by intravascular catheters (11/41). Most strains tested were susceptible to ceftazidime (95%), piperacillin (93%), minocycline (85%), and cefotaxime (82%); but most were resistant to aminoglycosides, tetracycline, carbenicillin, and ticarcillin. For empirical therapy of B. cepacia bacteremia, ceftazidime or piperacillin should be the drug of choice. |
本系統中英文摘要資訊取自各篇刊載內容。